Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
- Status
- COMPLETED
- Phase
- N/A
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
- Status
- COMPLETED
- Phase
- PHASE2
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)
- Status
- COMPLETED
- Phase
- PHASE1
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- NA
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
- Status
- COMPLETED
- Phase
- N/A
Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)
- Status
- COMPLETED
- Phase
- PHASE2
Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema
- Status
- COMPLETED
- Phase
- N/A
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse
- Status
- TERMINATED
- Phase
- PHASE2
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
- Status
- UNKNOWN
- Phase
- PHASE2